Implications of pathogenetic and prognostic features for management of myelodysplastic syndromes.
Greenberg
P
P
Hematology Division, Palo Alto VA Health Care System, Stanford University Medical Center, Palo Alto, CA 94304, USA. peterg@stanford.edu
D017209:Apoptosis; D001854:Bone Marrow Cells / Q000502:physiology; D019450:Genes, MDR; D006410:Hematopoiesis; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy*; D011379:Prognosis